Healio (2/27, Welsh) reported, “Daily or near daily aspirin use reduced the risk for nonmucinous ovarian cancer across most strata of genetic risk based on a polygenic score, according to a case-control study” that “pooled individual-level data from eight population-based case-control studies.” The findings were published in JAMA Network Open.
